04:46

First-Line Nivolumab/Ipilimumab Improves Survival in Unresectable Hepatocellular Carcinoma

07:52

Nivo+Gem/Cis Is Durable, Improves Survival in Patients With Lymph Node–Only mUC

06:43

Neoadjuvant Nivolumab + Ipilimumab Could Be New SOC in Stage III Melanoma

04:11

CROSS Inferior to FLOT in Patients With Esophageal Adenocarcinoma

05:52

Telehealth Equally Effective as In-Person Palliative Care in Maintaining QOL in Advanced Lung Cancer

06:00

Osimertinib Improves PFS in EGFR-Mutant, Unresectable, Stage III NSCLC

05:08

Consolidation Durvalumab Could Be New SOC in Limited-Stage SCLC

03:32

Adagrasib Improves PFS in Patients With KRASG12C-Mutated NSCLC

04:55

Amivantamab + Lazertinib Administration Method May Affect Outcomes in Advanced NSCLC

00:57

Dr. Angela DeMichele on Why You Should Attend Our Flagship Best of ASCO Meeting

01:49

Dr. Melvin Chua Invites You to Register for #ASCOBT24

00:55

Save the Date for #ASCOBT24 August 8-10, 2024, in Yokohama, Japan

03:32

Dr. Melvin Chua on Why You Can't Miss #ASCOBT24

02:46

Systemic Treatment of Patients with Metastatic Breast Cancer: ASCO Resource-Stratified Guideline

02:16

Regional Affiliate Program

00:56

Find a World of Inspiration at #ASCO24

41:21

2024 Oncology Coding Updates

37:06

2024 CMS PFS Final Rule Updates

00:49

Dr. Samantha Siegel Shares Her Experience With ASCO Voices

00:47

Dr. Silke Gillessen Invites You to Attend ASCO #GU24

04:15

ASCO #GU24 Celebrates 20 Years!

00:41

Dr. George Chang on Why You Can't Miss ASCO #GI24

00:44

Dr. Rachna Shroff on Why You Should Attend ASCO #GI24

00:33

Dr. Todd Morgan on Why You Should Submit to ASCO #GU24

00:42

Dr. Silke Gillessen Invites You to Submit to ASCO #GU24

00:33

Dr. Rachna Shroff Invites You to Submit to ASCO #GI24

00:38

Dr. David Wang Invites You to Submit to ASCO #GI24

03:22

Evaluating Tarlatamab in Recurrent Small Cell Lung Cancer Treatment

03:49

What to Do with the Results of a Geriatric Assessment

04:21

How to Do a Geriatric Assessment

00:41

Dr. Roselle de Guzman Discusses How #ASCOBT23 Will Shape Future Cancer Care

00:37

Dr. Peter Paul Yu Highlights What Key Innovations Will Be Discussed at #ASCOBT23

02:39

Surgeon Quality and Patient Survival After Resection for Non–Small-Cell Lung Cancer

02:48

Impact of Prior Antibiotic Exposure on the Outcomes of Immune Checkpoint Inhibitor Immunotherapy

02:33

End-of-Life Systemic Oncologic Treatment in theImmunotherapy Era

02:16

Testing the Validity of a Prognostic Model for Castration-Resistant Prostate Cancer

07:10

ASCO Daily News 2023 Plenary Update - LBA1: INDIGO

11:42

ASCO Daily News 2023 Plenary Update - LBA2: PROSPECT

06:33

ASCO Daily News 2023 Plenary Update - LBA3: ADAURA

04:19

ASCO Daily News 2023 Plenary Update - LBA4: SWOG S1826

02:35

Effects of Molecular, Therapeutic, and Patient Factors on Outcome of Diffuse Low-Grade Glioma

02:27

Detecting and Managing T-DXd–Related Interstitial Lung Disease: The Five “S” Rules

02:40

Racial Inequities in the Pain Management of Patients with Advanced Cancers

02:41

Evaluating the Time Toxicity of Cancer Treatment in the CCTG CO.17 Trial

00:52

Dr. Raymond Osarogiagbon Invites You to Attend #ASCOQLTY23

02:25

Flow Cytometry for Measurement of Treatment Response in Acute Lymphoblastic Leukemia

02:59

Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer

00:48

Dr. Cardinale Smith on Why You Should Submit to the 2023 ASCO Quality Care Symposium

02:14

Cancer Screening in the United States During the Second Year of the COVID-19 Pandemic

03:10

Lidocaine Injection Prior to Breast Cancer Surgery Reduces the Risk of Metastasis

03:23

Results From the Phase I/IIa RELATIVITY-020 Trial

00:48

Dr. Sonali Smith Invites You to Register for the Best of #ASCO23

02:42

Deep Learning Based Predictor of Future Lung Cancer Risk

02:14

Cancer Risk Awareness Among Transgender and Nonbinary Persons

02:27

Triplet Therapy for Metastatic Hormone-sensitive Prostate Cancer

02:42

Data From a One-Stop-Shop Comprehensive Cancer Screening Center

01:20

Dr. Takayuki Yoshino Invites You to #ASCOBT23

02:18

Centralization of Initial Care and Improved Survival of Poor Patients With Breast Cancer

01:16

Dr. Peter Yu On Why You Don't Want to Miss #ASCOBT23

00:56

Dr. Tetsuya Mitsudomi On Why You Should Submit to #ASCOBT23